MEMBRANE PROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))
UNII ZGU6H3YYC7

Substance Identification & Data

This profile provides standardized clinical and technical data for Membrane Protein (severe Acute Respiratory Syndrome Coronavirus 2 (2019-ncov) (sars-cov-2)), uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZGU6H3YYC7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZGU6H3YYC7

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MEMBRANE PROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Membrane Protein (severe Acute Respiratory Syndrome Coronavirus 2 (2019-ncov) (sars-cov-2)). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

E1 GLYCOPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))

MATRIX GLYCOPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))

MEMBRANE GLYCOPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))

MEMBRANE PROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) (SARS-COV-2))

External Clinical & Regulatory Resources

Previous UNIIZGT9EY838C

Next UNIIZGV62C09KN